RD-BIOTECH will complete its biomanufacturing offer with a new plasmid DNA production unit, raw materials for innovative therapies (RNA vaccines, therapeutic mRNA, CAR-T cells, viral vectors, etc.)
These new cGMP-grade plasmid DNA biomanufacturing facilities will complement our current R&D-grade and “GMP-like” (High Quality Grade) pDNA bioproduction capabilities.

See you soon for a new episode! Follow with us the progress of the construction site

It's been a year since we moved into our new laboratories: A stimulating work environment, an experimented and dynamic team, quality laboratories & equipment! All the conditions are met to provide the best service, adapted to your needs.
Biomanufacturing of plasmids, antibodies, proteins or cells - Development of your biological tools - Do not hesitate to contact us!

RD-Biotech will present the fully comprehensive platform "From the engineering of the bacterial strain to the expression of your recombinant protein" at the "Cell Factories for Industrial Bioproduction" congress organized by ADEBIOTECH, March 29 and 30, 2022 at Biocitech, Romainville (Fr). This innovative service combines the expertise in microbiology of Smaltis, a company of the mAbexperts group, with the the well known expertise of RD-Biotech in DNA vector construction and recombinant proteins production. Come meet us on our booth https://asso.adebiotech.org/colloques/cell-factories-for-industrial-bioproduction/

From mg up to several grams, with a process and a quality grade adapted to your applications Contactez-nous pour plus d’informations !

For your antibody development projects, for applications in immunotherapy, diagnostics, research: contact our team of experts in molecular biology and antibody engineering: Contact us for more information!

On Thursday 30 September 2021, RD-Biotech was pleased to welcome Mr Jean-François Colombet, Prefect of the Doubs, as part of the France Relance plan, Résilience category.
Selected by the French government as part of the France Relance plan, the project to build a GMP-grade production unit will complement our current R&D grade and "High Quality Grade" ("GMP like") plasmid DNA biomanufacturing capacities, in order to answer the growing of market demand in new therapies. Construction will soon begin on the Temis Santé site

Link to the article: RD-Biotech: lauréat sur le volet Résilience - santé

Development / Production of monoclonal or recombinant antibodies - Expression vector construction - Antigen expression - DNA plasmid production...: Contact us for more information!

RD-BIOTECH, sees its project to build a production unit "Plasmids GMP" selected by the French State as the winner of the call for projects "AAP Recovery Plan for Industry - Strategic Sectors".
This production unit will complement our current plasma DNA bioproduction capabilities, R&D grade and "High Quality Grade", to meet a very fast growing demand of the new therapies market.

Link to the press release: RD-Biotech winner of the call for projects of France Relance!
Contact us for more information!

RD-Biotech was solicited to participate in this special file "Active ingredients" and present our activities of biomanufacturing of plasmid DNA.
Link to the article: RD-Biotech change de dimension

Contact us for more information!

RD-Biotech provides plasmid DNA production for more than 19 years for a wide range of research, preclinical, clinical and diagnostic applications. Our goal is to provide you with the most affordable, high-quality plasmid DNA manufacturing services that meet your requirements.

Discover our services from Molecular Biology
Contact us for more information!